UPDATED Dec 23, 2025
Discover large cap Belgian Pharmaceuticals & Biotech companies that are on the BEL20. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
UCB | €240.80 | 1.4% | 27.1% | €45.8b | €264.67 | PE34.3x | E17.5% | 0.6% | ||
ARGX | €720.60 | -0.8% | 19.2% | €44.1b | €811.50 | PE33.9x | E26.1% | n/a | ||
TUB | €215.00 | 0.9% | 52.5% | €9.6b | €230.50 | PE103.2x | n/a | 0.5% | ||
HYL | €5.94 | -2.6% | 11.2% | €166.3m | €13.20 | PS19.7x | E79.9% | n/a | ||
ALEMS | €4.62 | -14.4% | -27.1% | €19.6m | n/a | PE16.7x | n/a | n/a | ||
CYAD | €0.18 | 1.1% | -74.8% | €8.2m | n/a | PS44.3x | n/a | n/a | ||
BIOS | €0.0022 | -8.3% | -61.4% | €1.4m | n/a | PE-0.4x | n/a | n/a | ||
OXUR | €0.008 | -2.4% | -96.9% | €500.8k | n/a | PE0.3x | n/a | n/a |